Quantification of Bleomycin Pulmonary Toxicity in Mice by Changes in Lung Hydroxyproline Content and Morphometric Histopathology

作者: David M. Young , Branimir Ivan Sikic , Edward G. Mimnaugh , Theodore E. Gram

DOI:

关键词: ToxicityAndrologyParenchymaLungMedicineHistopathologyPathologyBleomycinPulmonary toxicityAlveolar WallHydroxyproline

摘要: Abstract Bleomycin treatment produced dose-dependent changes in lung collagen content and several measurable histopathological parameters. NIH/Swiss mice were treated twice weekly for 6 weeks with bleomycin, 0, 1, 20, or 40 mg/kg s.c. The two highest doses mortalities of 35 100%, respectively, as well loss body weight increase wet weight. Lung hydroxyproline content, an index collagen, increased to 50% above control levels at 8 after initiation bleomycin 20 mg/kg. Morphometric analysis was applied the following parameters light microscopy: number intraalveolar macrophages leukocytes, total pulmonary cell count, alveolar wall thickness, percentage consolidation parenchyma. increases all these compared controls. most marked occurred cells, which group given rose 150, 190, 210% controls 4, 6, weeks. lowest dose 1 weeks, evoked no other toxicity by examined. This model chronic may be useful analog development, testing potential antidotes, examining effects factors that might modify bleomycin.

参考文章(13)
A. Guzzon, G. Bonadonna, S. Monfardini, M. De Lena, Clinical, radiologic, and histopathologic studies on pulmonary toxicity induced by treatment with bleomycin (NSC-125066). Cancer chemotherapy reports. ,vol. 56, pp. 343- 356 ,(1972)
Ferenc Gyorkey, Harris Busch, Phyllis Gyorkey, Yerach Daskal, Ultrastructural Study of Pulmonary Bleomycin Toxicity Cancer Research. ,vol. 36, pp. 1267- 1272 ,(1976)
Ewald R. Weibel, Morphometry of the Human Lung ,(2013)
Carlos W. M. Bedrpssian, Mario A. Luna, Bruce Mackay, Benjamin Lichtiger, Ultrastructure of pulmonary bleomycin toxicity Cancer. ,vol. 32, pp. 44- 51 ,(1973) , 10.1002/1097-0142(197307)32:1<44::AID-CNCR2820320106>3.0.CO;2-Q
Milos Chvapil, Yei Mei Peng, Oxygen and Lung Fibrosis Archives of Environmental Health. ,vol. 30, pp. 528- 532 ,(1975) , 10.1080/00039896.1975.10666770
Ronald H. Blum, Stephen K. Carter, Karl Agre, A clinical review of bleomycin—a new antineoplastic agent Cancer. ,vol. 31, pp. 903- 914 ,(1973) , 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N
R. W. Fleischman, J. R. Baker, G. R. Thompson, U. H. Schaeppi, V. R. Illievski, D. A. Cooney, R. D. Davis, Bleomycin-induced interstitial pneumonia in dogs Thorax. ,vol. 26, pp. 675- 682 ,(1971) , 10.1136/THX.26.6.675
Chvapil M, Hollinger Ma, Effect of paraquat on rat lung prolyl hydroxylase. Research communications in chemical pathology and pharmacology. ,vol. 16, pp. 159- 162 ,(1977)
Mario A. Luna, Carlos W. M. Bedrossian, Benjamin Lichticer, Philip A. Salem, Interstitial Pneumonitis Associated with Bleomycin Therapy American Journal of Clinical Pathology. ,vol. 58, pp. 501- 510 ,(1972) , 10.1093/AJCP/58.5.501